Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral δ-opioid receptors

Katsumi Shinoda, Victor J Hruby, Frank Porreca

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The possible antihyperalgesic and antiallodynic activity of loperamide, an opioid agonist which does not readily penetrate the blood-brain barrier, were examined in the spinal nerve ligation model of experimental neuropathic pain. Intraperitoneal (i.p.) injection of loperamide effectively reversed thermal hyperalgesia. In contrast, loperamide had minimal effects on cold allodynia and no effects on mechanical allodynia. The antihyperalgesic action of loperamide against noxious heat was antagonized by naltrindole, a δ-opioid receptor selective antagonist, but not by pretreatment with β-funaltrexamine, a μ-opioid receptor selective antagonist, or administration of nor-binaltorphimine, a κ-opioid receptor selective antagonist. Furthermore, i.p. injection of [d-Ala2, Glu4]-deltorphin II, a δ-opioid receptor selective peptide agonist, also reversed thermal hyperalgesia. The present results suggest that thermal hyperalgesia in experimental neuropathic pain can be reduced through activation of peripheral δ-opioid receptors. The data suggest the possible application of peripherally restricted and δ-opioid receptor selective agonists in the treatment of some aspects of neuropathic pain without many of the side effects associated with centrally acting opioids and without the peripheral side effects of opioid agonists acting at μ-receptors.

Original languageEnglish (US)
Pages (from-to)143-146
Number of pages4
JournalNeuroscience Letters
Volume411
Issue number2
DOIs
StatePublished - Jan 10 2007

Fingerprint

Loperamide
Hyperalgesia
Opioid Receptors
Neuralgia
Narcotic Antagonists
Opioid Analgesics
naltrindole
Intraperitoneal Injections
Spinal Nerves
Blood-Brain Barrier
Ligation
Theoretical Models
Hot Temperature
Peptides

Keywords

  • Loperamide
  • Neuropathic pain
  • Peripheral δ-opioid receptors
  • Thermal hyperalgesia

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral δ-opioid receptors. / Shinoda, Katsumi; Hruby, Victor J; Porreca, Frank.

In: Neuroscience Letters, Vol. 411, No. 2, 10.01.2007, p. 143-146.

Research output: Contribution to journalArticle

@article{50aa6bcf69004cfe896818d16966bc22,
title = "Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral δ-opioid receptors",
abstract = "The possible antihyperalgesic and antiallodynic activity of loperamide, an opioid agonist which does not readily penetrate the blood-brain barrier, were examined in the spinal nerve ligation model of experimental neuropathic pain. Intraperitoneal (i.p.) injection of loperamide effectively reversed thermal hyperalgesia. In contrast, loperamide had minimal effects on cold allodynia and no effects on mechanical allodynia. The antihyperalgesic action of loperamide against noxious heat was antagonized by naltrindole, a δ-opioid receptor selective antagonist, but not by pretreatment with β-funaltrexamine, a μ-opioid receptor selective antagonist, or administration of nor-binaltorphimine, a κ-opioid receptor selective antagonist. Furthermore, i.p. injection of [d-Ala2, Glu4]-deltorphin II, a δ-opioid receptor selective peptide agonist, also reversed thermal hyperalgesia. The present results suggest that thermal hyperalgesia in experimental neuropathic pain can be reduced through activation of peripheral δ-opioid receptors. The data suggest the possible application of peripherally restricted and δ-opioid receptor selective agonists in the treatment of some aspects of neuropathic pain without many of the side effects associated with centrally acting opioids and without the peripheral side effects of opioid agonists acting at μ-receptors.",
keywords = "Loperamide, Neuropathic pain, Peripheral δ-opioid receptors, Thermal hyperalgesia",
author = "Katsumi Shinoda and Hruby, {Victor J} and Frank Porreca",
year = "2007",
month = "1",
day = "10",
doi = "10.1016/j.neulet.2006.10.027",
language = "English (US)",
volume = "411",
pages = "143--146",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral δ-opioid receptors

AU - Shinoda, Katsumi

AU - Hruby, Victor J

AU - Porreca, Frank

PY - 2007/1/10

Y1 - 2007/1/10

N2 - The possible antihyperalgesic and antiallodynic activity of loperamide, an opioid agonist which does not readily penetrate the blood-brain barrier, were examined in the spinal nerve ligation model of experimental neuropathic pain. Intraperitoneal (i.p.) injection of loperamide effectively reversed thermal hyperalgesia. In contrast, loperamide had minimal effects on cold allodynia and no effects on mechanical allodynia. The antihyperalgesic action of loperamide against noxious heat was antagonized by naltrindole, a δ-opioid receptor selective antagonist, but not by pretreatment with β-funaltrexamine, a μ-opioid receptor selective antagonist, or administration of nor-binaltorphimine, a κ-opioid receptor selective antagonist. Furthermore, i.p. injection of [d-Ala2, Glu4]-deltorphin II, a δ-opioid receptor selective peptide agonist, also reversed thermal hyperalgesia. The present results suggest that thermal hyperalgesia in experimental neuropathic pain can be reduced through activation of peripheral δ-opioid receptors. The data suggest the possible application of peripherally restricted and δ-opioid receptor selective agonists in the treatment of some aspects of neuropathic pain without many of the side effects associated with centrally acting opioids and without the peripheral side effects of opioid agonists acting at μ-receptors.

AB - The possible antihyperalgesic and antiallodynic activity of loperamide, an opioid agonist which does not readily penetrate the blood-brain barrier, were examined in the spinal nerve ligation model of experimental neuropathic pain. Intraperitoneal (i.p.) injection of loperamide effectively reversed thermal hyperalgesia. In contrast, loperamide had minimal effects on cold allodynia and no effects on mechanical allodynia. The antihyperalgesic action of loperamide against noxious heat was antagonized by naltrindole, a δ-opioid receptor selective antagonist, but not by pretreatment with β-funaltrexamine, a μ-opioid receptor selective antagonist, or administration of nor-binaltorphimine, a κ-opioid receptor selective antagonist. Furthermore, i.p. injection of [d-Ala2, Glu4]-deltorphin II, a δ-opioid receptor selective peptide agonist, also reversed thermal hyperalgesia. The present results suggest that thermal hyperalgesia in experimental neuropathic pain can be reduced through activation of peripheral δ-opioid receptors. The data suggest the possible application of peripherally restricted and δ-opioid receptor selective agonists in the treatment of some aspects of neuropathic pain without many of the side effects associated with centrally acting opioids and without the peripheral side effects of opioid agonists acting at μ-receptors.

KW - Loperamide

KW - Neuropathic pain

KW - Peripheral δ-opioid receptors

KW - Thermal hyperalgesia

UR - http://www.scopus.com/inward/record.url?scp=33751417924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751417924&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2006.10.027

DO - 10.1016/j.neulet.2006.10.027

M3 - Article

C2 - 17110034

AN - SCOPUS:33751417924

VL - 411

SP - 143

EP - 146

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -